Reducing Patient Dropout Rates and Accelerating Trial Completion

Publication
Video
Conferences|Drug Information Association (DIA) Annual Meeting

Jon Ernst (Vice President, In-Home Solutions, Decentralized Clinical Trials) discusses today's clinical trial landscape.

Jon Ernst talked with ACT about how PCM Trials are harmonizing various elements in the decentralized clinical trial process.

Learn More About:

  • The benefits of home visits in decentralized clinical trials
  • What to look for in a home visit vendor for a successful study
  • How home visits and community research sites have been misunderstood
Recent Videos
Related Content
DIA 2024: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology

DIA 2024: Improving Patient Access to Clinical Trials Through Decentralization and Flexible Design: Lessons from Oncology

Don Tracy, Associate Editor
June 20th 2024
Article

Breakout session discusses the impact of incorporating decentralized elements into oncology clinical trials on data integrity, patient safety, and regulatory approvals.

DIA 2024: Machine Learning and Simulations to Facilitate Clinical Trials

DIA 2024: Machine Learning and Simulations to Facilitate Clinical Trials

Andy Studna, Editor
June 17th 2024
Article

Session highlights the value of simulations such as data analysis and endpoint selection in clinical development.

DIA 2023 Recap: Q&A with DIA President and Global Chief Executive, Marwan Fathallah

DIA 2023 Recap: Q&A with DIA President and Global Chief Executive, Marwan Fathallah

August 17th 2023
Article

Fathallah shares his thoughts on the recent DIA 2023 Annual Meeting in Boston, MA.

Janice Chang, CEO, TransCelerate BioPharma | © photo from video

Importance of DCTs Moving Forward

August 9th 2023
Article

Perceived barriers of DCTs can be quickly overcome to ensure their viability in clinical research.

When Clinical Trial Professionals Participate in a Study

When Clinical Trial Professionals Participate in a Study

Lisa Henderson
July 31st 2023
Article

DIA 2023 panel discussed personal experiences in clinical trials and offer suggestions for improvements to focus on the participants.

DIA 2023: How Did Biofourmis Get Involved with CancerX?

DIA 2023: How Did Biofourmis Get Involved with CancerX?

July 27th 2023
Article

Jaydev Thakkar, chief operating officer, Biofourmis discusses how Biofourmis got involved with the CancerX Initiative at the 2023 DIA annual meeting in Boston, MA.

© 2024 MJH Life Sciences

All rights reserved.